Harvard and Northwestern researchers combine AI and physics to design unstable proteins that comprise the dark proteome.

The integration of single-cell RNA sequencing (scRNA-seq) with AI has become a cornerstone for deciphering tumor heterogeneity. For instance, in pancreatic ductal adenocarcinoma (PDAC), spatial ...

The integration of artificial intelligence (AI) into drug discovery is revolutionizing pharmaceutical research by providing sophisticated tools for understanding and predicting complex biological ...

Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...

In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.

(Reuters) -U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical, deepening their use of artificial intelligence ...

New to The Street, one of America's leading business television and multi-platform media brands, today announced a ...

An artificial intelligence (AI) model trained on complex data from human cells could provide a shortcut in the race to develop new drugs 1. The approach, published on 23 October in Science, builds on ...

Explore Cerebras’s new Oklahoma data center, the fastest AI facility globally, featuring 44 exaflops of power and innovative technologies.

The Indian Institute of Technology-Madras announced a breakthrough artificial intelligence framework that can rapidly generate drug-like molecules that are easier to synthesise in real-world ...

The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...